Market revenue in 2023 | USD 1,338.2 million |
Market revenue in 2030 | USD 2,478.4 million |
Growth rate | 9.2% (CAGR from 2023 to 2030) |
Largest segment | Aneroid blood pressure monitors |
Fastest growing segment | Digital Blood Pressure Monitors |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Aneroid Blood Pressure Monitors, Digital Blood Pressure Monitors, Ambulatory Blood Pressure Monitors, Blood Pressure Transducers, Instrument & Accessories |
Key market players worldwide | OMRON Corp, A&D Medical, SunTech Medical, American Diagnostic Sciences, Nokia Oyj, Briggs Healthcare Corp., GE HealthCare Technologies Inc Common Stock, Microlife Corp, Procter & Gamble Co, Spacelabs Healthcare, Koninklijke Philips NV, Hill-Rom, B. Braun, CONTEC, Kaz, Inc., Rossmax International, Biobeat |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood pressure monitoring devices market will help companies and investors design strategic landscapes.
Aneroid blood pressure monitors was the largest segment with a revenue share of 33.57% in 2023. Horizon Databook has segmented the Europe blood pressure monitoring devices market based on aneroid blood pressure monitors, digital blood pressure monitors, ambulatory blood pressure monitors, blood pressure transducers, instrument & accessories covering the revenue growth of each sub-segment from 2018 to 2030.
The imminent implementation of In-vitro Diagnostics Regulation (IVDR) and new Medical Device Regulation (MDR) is anticipated to drastically change medical devices regulatory scenario in the European Union.
Some of the key changes expected to occur on implementation of these regulations are costly certification of new products & recertification of existing products, due to reclassification of devices as per new regulations, and increased requirements for clinical testing of medical devices, especially for IVDs.
These new regulations are anticipated to increase the time and cost required to enter a European market. However, in September 2020, CardieX Limited announced that its subsidiary ATCOR received European Patent Office’s approval for its SphygmoCor technology.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe blood pressure monitoring devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe blood pressure monitoring devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account